ロード中...
Differentiating founder and chronic HIV envelope sequences
Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV envelope glycoprotein Env, but an effective vaccine has proven elusive. Vaccine development would be facilitated if common features of early founder virus required for transmission could be identifie...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302377/ https://ncbi.nlm.nih.gov/pubmed/28187204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0171572 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|